Does TRT Improve Sleep or Make It Worse?

TRT can do both — and which outcome you get depends heavily on whether you have obstructive sleep apnea (OSA), what dose you're on, and whether your testosterone is being restored to a physiologic range or pushed past it. The evidence is clear enough to take a position: in genuinely hypogonadal men without significant OSA, TRT tends to improve sleep; in men with undiagnosed or untreated OSA, it can meaningfully worsen it.

When TRT Helps Sleep

Low testosterone and poor sleep are genuinely bidirectional. Research published in JCEM shows that men with lower testosterone have reduced sleep efficiency, more nocturnal awakenings, and less slow-wave sleep — the restorative deep-sleep stage. Travison et al. 2007 (JAMA) documented the steady age-related testosterone decline that tracks alongside the worsening sleep complaints men commonly report in their 40s and 50s. When testosterone is the missing variable, replacing it can close the loop.

The most direct clinical evidence comes from a subanalysis of the EARTH study, which followed hypogonadal men without OSA through 12 months of TRT. Men in the treatment arm showed statistically significant improvements in sleep disturbance scores, sexual function, and quality-of-life domains compared with controls [2]. The improvements weren't dramatic, but they were consistent — and the exclusion of OSA patients is the key methodological detail. These weren't men with an airway problem masquerading as a hormone problem.

Per Endocrine Society Clinical Practice Guidelines on male hypogonadism, dosing should target mid-normal serum testosterone (roughly 400–700 ng/dL). When topical gels like AndroGel or Testim are titrated to keep levels stable rather than spiking, the sleep benefit appears most durable [5].

When TRT Worsens Sleep

The OSA risk is real and shouldn't be minimized. A randomized trial by Hoyos et al. assigned obese men with severe OSA to intramuscular testosterone undecanoate or placebo alongside a calorie-restricted diet. At seven weeks, the testosterone group showed a significantly worsened oxygen desaturation index (+10.3 events/hour) and more time with SpO₂ below 90% [3]. The effect attenuated by week 18, but the early window of worsening is clinically meaningful — particularly for men who may not know they have OSA going in.

A large cohort study of transmasculine individuals on testosterone found substantially elevated hazard ratios for sleep apnea versus cisgender females and cisgender males, adding population-level weight to the mechanistic story [4]. The mechanism involves testosterone reducing upper airway dilator muscle responsiveness, potentially increasing pharyngeal collapsibility during sleep. Supraphysiologic dosing adds another layer: polysomnography studies show that high-dose testosterone enanthate can suppress REM sleep from roughly 20% to 13% of total sleep time [6].

Injectable formulations that create large peaks — think Depo-Testosterone at 200 mg every two weeks — carry higher sleep apnea risk than formulations that produce steadier levels. Men whose post-injection peak exceeded 1,100 ng/dL had approximately 2.3 times higher odds of a clinically significant AHI increase [7]. If you're working with a provider, that pharmacokinetic detail matters. Clinics that individualize TRT protocols based on peak-and-trough monitoring are better positioned to avoid this problem than those running cookie-cutter injection schedules — a point covered in depth in our piece on why monthly injection clinics tend to overcharge and undermonitor.

What to Do Before Starting TRT

The Endocrine Society guidelines list untreated severe OSA as a relative contraindication to initiating TRT. That means a sleep history — snoring, witnessed apneas, daytime sleepiness — isn't optional intake paperwork. It's a clinical requirement. If STOP-BANG screening comes back high, polysomnography before starting TRT is reasonable. Men already on CPAP with a controlled apnea-hypopnea index can generally proceed with appropriate monitoring.

Once TRT is underway, hematocrit should be checked at 3–6 months. The Endocrine Society recommends pausing therapy if hematocrit exceeds 54%, evaluating for hypoxia, and screening for OSA before restarting at a lower dose [5]. That hematocrit threshold is directly connected to sleep apnea risk — erythrocytosis compounds nocturnal hypoxemia in men with airway issues. For men weighing their options, the relationship between testosterone and systemic health is more interconnected than most realize; our post on how TRT affects relationships and mood covers some of those downstream effects. Comparing providers who actually run these panels is straightforward through the TRT provider directory.

---

Frequently asked questions

Does TRT cause sleep apnea?

TRT does not cause sleep apnea in men with no predisposition, but it can worsen existing or subclinical OSA, particularly in the first weeks of treatment and at supraphysiologic doses. The Hoyos randomized trial found measurable worsening of oxygen desaturation in obese men with severe OSA at seven weeks, though effects attenuated by week 18 [3]. Men with obesity, large neck circumference, or a history of snoring should be screened before starting testosterone therapy.

Will TRT help me sleep better if my testosterone is low?

In genuinely hypogonadal men without significant sleep-disordered breathing, TRT is more likely to improve sleep than worsen it. The EARTH study subanalysis found statistically significant improvements in sleep disturbance scores over 12 months compared with controls [2]. If